The Enigma of FGF23 Dysregulation in Von Recklinghausen’s Disease: A Case of Hypophosphatemic Osteomalacia with a Neurofibromin 1 Gene (c.6772C>T; p.Arg2258Ter) Mutation
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Neurofibromatosis type 1 (NF-1) or Von Recklinghausen’s disease is an autosomal dominant disorder characterised by a variety of systemic manifestations including skeletal abnormalities. Hypophosphatemic Osteomalacia (HO) is a rare but significant complication associated with NF-1 primarily driven by Fibroblast Growth Factor 23 (FGF23)-mediated phosphate wasting. Case Presentation: We report the case of a 54-year-old male with NF-1 presenting with progressive proximal muscle weakness and osteomalacia. Diagnostic workup revealed insufficiency fractures, severe hypophosphatemia and increased FGF23 levels, suggestive of FGF23-mediated HO. Additional findings included a peri-ampullary neuroendocrine tumor and a Gastrointestinal Stromal Tumor (GIST). Genetic testing identified a heterozygous pathogenic variant (c.6772C>T; p.Arg2258Ter) in the NF-1 gene. The patient was managed with phosphate and calcitriol supplementation, leading to clinical and radiological improvement. Conclusion: Very few patients of Neurofibromatosis type 1 expressing HO is mysterious. NF-1-associated HO requires heightened clinical awareness for early diagnosis and intervention to alleviate the morbidity.
Fields of Study & Subjects
Parathyroid Disorders and Treatments
Neurofibromatosis and Schwannoma Cases
Alkaline Phosphatase Research Studies
Publication details
- Journal / source
- Archives of Endocrinology and Disorders
- Volume
- 2
- Issue
- 1
- Pages
- 1–11
- Publication date
- 28 March 2026
- Language
- EN